Azathioprine as a Treatment for Severe Atopic Eczema in Children with a Partial Thiopurine Methyl Transferase (TPMT) Deficiency

Pediatric Dermatology

Volumn 20, Issue 6, 2003, Pages 531-534

  Murphy, Lesley Ann ^a   Atherton, David J ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; BACTERICIDE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PSORALEN; THIOPURINE METHYLTRANSFERASE;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; BONE MARROW SUPPRESSION; CASE REPORT; CHILD; CHOLESTASIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG HYPERSENSITIVITY; ECZEMA; ENZYME DEFICIENCY; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; GROWTH DISORDER; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; MALE; MEGALOCYTOSIS; MOOD DISORDER; PRIORITY JOURNAL; SCABIES; SIDE EFFECT; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; AZATHIOPRINE; CHILD; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; ECZEMA; HUMANS; MALE; METHYLTRANSFERASES; SEVERITY OF ILLNESS INDEX;

EID: 0345802817     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2003.20617.x     Document Type: Article

References (11)

1. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 1996;34:760-764.
2. Sugiura H, Umemoto N, Deguchi H, et al. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol 1998;78:293-294.
3. Laughter D, Istvan J, Tofte S, Hanafin J. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000;43:649-655.
4. Salek MS, et al. Cyclosporine greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993;129:422-430.
5. Bennett JA, Christian JM. Cyclosporine-induced gingival hyperplasia: case report and literature review. J Am Dent Assoc 1985;111:272-273.
6. Lear JT, et al. Retrospective review of the use of azathioprine in severe atopic dermatitis. J Am Acad Dermatol 1996;35:642-643.
7. Buckley DA, Baldwin P, Rogers S. The use of azathioprine in severe atopic eczema. J Eur Acad Dermatol Venereol 1998;11:137-140.
8. Chocair PR, et al. Thiopurine methyltransferase activity and efficacy of azathioprine immunosuppression in transplant recipients. Adv Exp Med Biol 1991;309A: 61-64.
9. Murphy LA, Atherton DJ. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyl transferase levels to exclude patients at high risk of myelosuppression. Br J Dermatol 2002;147:308-315.
10. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651-662.
11. Dubinski MC, et al. Pharmacogenetics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-713.